Goldman Sachs Starts Adeptus Biotechnologies Corp. (ADPT) at Buy
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $24.74 +1.14%
Rating Summary:
13 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
13 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Goldman Sachs analyst Salveen Richter initiates coverage on Adeptus Biotechnologies Corp. (NASDAQ: ADPT) with a Buy rating and a price target of $60.00.
For an analyst ratings summary and ratings history on Adeptus Biotechnologies Corp. click here. For more ratings news on Adeptus Biotechnologies Corp. click here.
Shares of Adeptus Biotechnologies Corp. closed at $38.82 yesterday.
You May Also Be Interested In
- Seaport Global Securities Starts ADI Global Distribution (ADIG) at Buy
- Leerink Starts Ligand Pharma (LGND) at Outperform
- Lake Street Starts RF Industries Ltd. (RFIL) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
